Показано 0 из 0
Дата |
---|
03.05.2024 |
02.05.2024 |
01.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
1.12
|
1.17
|
1.19
|
1.16
|
1.19
|
1.17
|
|
|
115 516.43
|
504.00
|
1.12
|
1.24
|
1.15
|
1.125
|
1.17
|
1.17
|
|
|
181 702.27
|
634.00
|
1.12
|
1.15
|
1.08
|
1.08
|
1.15
|
1.12
|
|
|
254 360.31
|
735.00
|
1.06
|
1.11
|
1.09
|
1.08
|
1.1101
|
1.11
|
|
|
104 148.90
|
403.00
|
1.05
|
1.12
|
1.09
|
1.09
|
1.13
|
1.09
|
|
|
136 620.35
|
413.00
|
1.06
|
1.15
|
1.09
|
1.06
|
1.10
|
1.09
|
|
|
236 677.63
|
537.00
|
1.05
|
1.10
|
1.03
|
1.03
|
1.1201
|
1.08
|
|
|
328 185.02
|
763.00
|
1.03
|
1.15
|
1.05
|
1.0294
|
1.0675
|
1.06
|
|
|
64 788.05
|
243.00
|
1.02
|
1.12
|
1.04
|
1.04
|
1.07
|
1.06
|
|
|
64 132.15
|
287.00
|
1.04
|
1.05
|
1.05
|
1.03
|
1.08
|
1.04
|
|
|
116 055.99
|
568.00
|
Oncolytics Biotech Inc., a development stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer.